Back to Search
DANIEL SLAUGHTER, M.D.
M.D.
Specialist
NPI: 1477527778IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
J0268(TX)
Education
BAYLOR COLLEGE OF MEDICINE
Class of 1990
Research & Publications (20)
Use of an interactive teaching modality in predoctoral oral and maxillofacial surgery.
PMID 19138611·J Oral Maxillofac Surg·2009
8-other
Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer.
PMID 18578472·J Med Chem·2008
8-other
The Radiation Injury Severity Classification system: an early injury assessment tool for the frontline health-care provider.
PMID 18180264·Br J Radiol·2008
8-other
Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP.
PMID 17804233·Bioorg Med Chem Lett·2007
7-preclinical
Uncertainties analysis for the plutonium dosimetry model, doses-2005, using Mayak bioassay data.
PMID 17693771·Health Phys·2007
8-other
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP.
PMID 16603356·Bioorg Med Chem Lett·2006
7-preclinical
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility.
PMID 16439122·Bioorg Med Chem Lett·2006
7-preclinical
Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilic alpha,beta-unsaturated iminium species that results in the selective mechanism-based inactivation of the enzyme.
PMID 16167835·Chem Res Toxicol·2005
7-preclinical
Uncertainties analysis of doses resulting from chronic inhalation of plutonium at the Mayak production association.
PMID 15951690·Health Phys·2005
4-observational
Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
PMID 14570767·Drug Metab Dispos·2003
8-other
Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective I(Ks)-blocking class III antiarrhythmic agents.
PMID 12643935·Bioorg Med Chem Lett·2003
7-preclinical
Calculated organ doses for Mayak production association central hall using ICRP and MCNP.
PMID 12645766·Health Phys·2003
8-other
Metabolism of rofecoxib in vitro using human liver subcellular fractions.
PMID 14570773·Drug Metab Dispos·2003
8-other
The historical and current application of the FIB-1 model to assess organ dose from plutonium intakes in Mayak workers.
PMID 11906133·Health Phys·2002
4-observational
Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor.
PMID 11353749·Drug Metab Dispos·2001
7-preclinical
Antibiotic resistance in coagulase-negative staphylococci isolated from Cope's gray treefrogs (Hyla chrysoscelis).
PMID 11750814·FEMS Microbiol Lett·2001
7-preclinical
Antimicrobial susceptibility of staphylococci isolated from the faeces of wild turkeys (Meleagris gallopavo).
PMID 11696101·Lett Appl Microbiol·2001
7-preclinical
The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach.
PMID 11689122·J Biomol Screen·2001
8-other
The effect of fungal species on the fluorescent lectin test.
PMID 11438183·J Microbiol Methods·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12221 RENFERT WAY, SUITE 110
AUSTIN, TX 78758 - Phone
- (512) 601-0303
Quick Facts
- NPI
- 1477527778
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile